Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis is a research paper published in Annals of Clinical and Translational Neurology (2025). On theSindex it has a DataRank of 0.453. It has been cited 14 times, with 10 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0.0467
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
National Institute of Neurological Disorders and Stroke
Grant: NS115426‐01A1
National Institute of Neurological Disorders and Stroke
Grant: R25NS088248
National Institute of Neurological Disorders and Stroke
Grant: R44NS137943
NINDS NIH HHS
Grant: NS115426-01A1
NINDS NIH HHS
Grant: R44 NS115426
Cartesian Therapeutics
Cartesian Therapeutics
FWCI
10.08
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords